Which test is most accurate for diagnosing and tracking progression of chronic obstructive pulmonary disease?

Enhance your PEAT Series 2 Form B Test preparation with structured questions and detailed insights. Understand test formats with explanations and ace your exam!

Multiple Choice

Which test is most accurate for diagnosing and tracking progression of chronic obstructive pulmonary disease?

Explanation:
Pulmonary function testing, especially spirometry, directly measures the airflow limitation that defines COPD, making it the most accurate test for both diagnosing the disease and tracking its progression. When performed with a bronchodilator, spirometry provides a post-bronchodilator FEV1/FVC ratio that confirms COPD, and repeating these measurements over time shows how rapidly FEV1 declines, helping to gauge severity and progression (often categorized by GOLD stages). Arterial blood gas looks at gas exchange and hypoxemia, but it doesn’t diagnose COPD or track its course as reliably. A chest radiograph can reveal structural changes like hyperinflation but is insensitive for detecting early COPD. A maximal exercise test assesses exercise capacity, which is useful for functional status but not the primary method for diagnosing COPD or monitoring its progression.

Pulmonary function testing, especially spirometry, directly measures the airflow limitation that defines COPD, making it the most accurate test for both diagnosing the disease and tracking its progression. When performed with a bronchodilator, spirometry provides a post-bronchodilator FEV1/FVC ratio that confirms COPD, and repeating these measurements over time shows how rapidly FEV1 declines, helping to gauge severity and progression (often categorized by GOLD stages).

Arterial blood gas looks at gas exchange and hypoxemia, but it doesn’t diagnose COPD or track its course as reliably. A chest radiograph can reveal structural changes like hyperinflation but is insensitive for detecting early COPD. A maximal exercise test assesses exercise capacity, which is useful for functional status but not the primary method for diagnosing COPD or monitoring its progression.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy